| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ernexa Therapeutics Inc. (ERNA) has 0 insiders with recent SEC Form 4 filings, including 18 buys and 0 sells. ERNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 25, 2019 | Ellin Robert S63 | 10% Owner | Buy | 302 | $3.09 | $934.03 | - | |
| Oct 23, 2019 | Ellin Robert S63 | 10% Owner | Buy | 4,801 | $2.78 | $13,331.98 | +1.4% | |
| Oct 14, 2019 | Ellin Robert S63 | 10% Owner | Buy | 100 | $3.50 | $350.00 | - | |
| Oct 14, 2019 | Ellin Robert S63 | 10% Owner | Buy | 300 | $3.66 | $1,097.01 | +0.2% | |
| Oct 8, 2019 | Ellin Robert S63 | 10% Owner | Buy | 100 | $3.67 | $367.00 | - | |
| Oct 4, 2019 | Ellin Robert S63 | 10% Owner | Buy | 393 | $3.05 | $1,198.65 | - | |
| Oct 1, 2019 | Ellin Robert S63 | 10% Owner | Buy | 300 | $3.50 | $1,051.00 | - | |
| Sep 26, 2019 | Ellin Robert S63 | 10% Owner | Buy | 4,831 | $2.95 | $14,245.17 | +2.5% | |
| Sep 25, 2019 | Ellin Robert S63 | 10% Owner | Buy | 28,700 | $2.51 | $71,948.37 | +8.3% | |
| Sep 13, 2019 | Ellin Robert S63 | 10% Owner | Buy | 9,002 | $2.26 | $20,367.58 | +2.9% |